Ra Capital Management, L.P. Essa Pharma Inc. Transaction History

Ra Capital Management, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 16, 2021	SELL	$5.47 - $12.1 $2.57 Million - $5.69 Million	-470,428 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$6.0 - $7.79 $2.27 Million - $2.95 Million	-378,872 Reduced 44.61%	470,428 $3.25 Million
Q2 2020 Aug 14, 2020	SELL	$3.71 - $6.2 $408,100 - $682,000	-110,000 Reduced 11.47%	849,300 $5.27 Million
Q1 2020 May 15, 2020	SELL	$3.23 - $5.87 $131,461 - $238,909	-40,700 Reduced 4.07%	959,300 $3.84 Million
Q3 2019 Nov 14, 2019	BUY	$1.46 - $3.37 $1.46 Million - $3.37 Million	1,000,000 New	1,000,000 $3.37 Million

31M

24.1K

15.1K

Ticker EPIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,073,100
Market Cap $75.8M
Description
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses on developing novel and proprietary therapies for the treatment of prostate cancer. It develops EPI-7386, an oral candidate that is in a Phase I clinical study for the treatment of patients with metastatic castration-resistant prostate cancer. The company has collaboration agreem...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.